Syndax Pharmaceuticals's total assets for Q1 2025 were $640.71M, a decrease of -11.60% from the previous quarter. SNDX total liabilities were $331.10M for the fiscal quarter, a -24.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.